Waverly Hematology Oncology — Cary, North Carolina

Waverly Hematology Oncology is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Waverly Hematology Oncology has participated in 47 clinical trials with 18 currently active.

Therapeutic areas: Metastatic Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8.

Sponsors: Dompé Farmaceutici S.p.A, Alliance for Clinical Trials in Oncology, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cary

Browse all research sites in North Carolina · View every site in Cary

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Waverly Hematology Oncology?

Waverly Hematology Oncology has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Waverly Hematology Oncology conducted?

Waverly Hematology Oncology has 47 clinical trials on record, with 18 currently active. Their work covers Metastatic Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8.

Is Waverly Hematology Oncology accredited by Crixeo Clinical Trials?

Waverly Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Waverly Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.